Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 2
2019 1
2020 9
2021 7
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challenges.
Chatterjee G, Dhende P, Raj S, Shetty V, Ghogale S, Deshpande N, Girase K, Patil J, Kalra A, Narula G, Dalvi K, Dhamne C, Moulik NR, Rajpal S, Patkar NV, Banavali S, Gujral S, Subramanian PG, Tembhare PR. Chatterjee G, et al. Among authors: patkar nv. Eur J Haematol. 2024 Jan;112(1):122-136. doi: 10.1111/ejh.14102. Epub 2023 Sep 14. Eur J Haematol. 2024. PMID: 37706583
Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B-lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease.
Chatterjee G, Sriram H, Ghogale S, Deshpande N, Khanka T, Girase K, Verma S, Arolkar G, Dasgupta N, Narula G, Shetty D, Dhamne C, Moulik NR, Rajpal S, Patkar NV, Banavali S, Gujral S, Subramanian PG, Tembhare PR. Chatterjee G, et al. Among authors: patkar nv. Br J Haematol. 2022 Jan;196(2):374-379. doi: 10.1111/bjh.17801. Epub 2021 Sep 2. Br J Haematol. 2022. PMID: 34476808
Improved protocol for plasma microRNA extraction and comparison of commercial kits.
Sriram H, Khanka T, Kedia S, Tyagi P, Ghogale S, Deshpande N, Chatterjee G, Rajpal S, Patkar NV, Subramanian PG, Gujral S, Hasan S, Tembhare PR. Sriram H, et al. Among authors: patkar nv. Biochem Med (Zagreb). 2021 Oct 15;31(3):030705. doi: 10.11613/BM.2021.030705. Biochem Med (Zagreb). 2021. PMID: 34658646 Free PMC article.
Expression levels and patterns of B-cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent.
Sriram H, Kunjachan F, Khanka T, Gawai S, Ghogale S, Deshpande N, Girase K, Patil J, Chatterjee G, Rajpal S, Patkar NV, Bagal B, Jain H, Sengar M, Hasan SK, Khattry N, Subramanian PG, Gujral S, Tembhare PR. Sriram H, et al. Among authors: patkar nv. Cytometry B Clin Cytom. 2022 Nov;102(6):462-470. doi: 10.1002/cyto.b.22099. Epub 2022 Nov 8. Cytometry B Clin Cytom. 2022. PMID: 36346307 Free article.
Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre-myelomastocytic leukemia condition.
Panda D, Chatterjee G, Khanka T, Ghogale S, Badrinath Y, Deshpande N, Sardana R, Chaturvedi A, Rajpal S, Shetty D, Patkar NV, Gujral S, Subramanian PG, Tembhare PR. Panda D, et al. Among authors: patkar nv. Cytometry B Clin Cytom. 2021 May;100(3):331-344. doi: 10.1002/cyto.b.21938. Epub 2020 Aug 1. Cytometry B Clin Cytom. 2021. PMID: 32738100 Free article.
Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristics.
Panda D, Chatterjee G, Sardana R, Khanka T, Ghogale S, Deshpande N, Badrinath Y, Shetty D, Narula G, Banavali S, Patkar NV, Gujral S, Subramanian PG, Tembhare PR. Panda D, et al. Among authors: patkar nv. Cytometry B Clin Cytom. 2021 Mar;100(2):206-217. doi: 10.1002/cyto.b.21943. Epub 2020 Aug 31. Cytometry B Clin Cytom. 2021. PMID: 32865882 Free article.
Expression of CD304/neuropilin-1 in adult b-cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment.
Chatterjee G, Dudakia V, Ghogale S, Deshpande N, Girase K, Chaturvedi A, Shetty D, Senger M, Jain H, Bagal B, Bonda A, Punatar S, Gokarn A, Khattry N, Patkar NV, Gujral S, Subramanian PG, Tembhare PR. Chatterjee G, et al. Among authors: patkar nv. Int J Lab Hematol. 2021 Oct;43(5):990-999. doi: 10.1111/ijlh.13456. Epub 2021 Jan 12. Int J Lab Hematol. 2021. PMID: 33432783
Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusion.
Tembhare PR, Chatterjee G, Khanka T, Ghogale S, Badrinath Y, Deshpande N, Panda D, Patkar NV, Narula G, Girase K, Verma S, Sanyal M, Sriram HN, Banavali S, Gujral S, Subramanian PG. Tembhare PR, et al. Among authors: patkar nv. Cytometry B Clin Cytom. 2021 Jul;100(4):421-433. doi: 10.1002/cyto.b.21939. Epub 2020 Aug 19. Cytometry B Clin Cytom. 2021. PMID: 32812702 Free article.
18 results